ArticleInternational journal of clinical oncology2021

Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.

Tomokazu Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.